1. Home
  2. IMRX vs DBI Comparison

IMRX vs DBI Comparison

Compare IMRX & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • DBI
  • Stock Information
  • Founded
  • IMRX 2008
  • DBI 1991
  • Country
  • IMRX United States
  • DBI United States
  • Employees
  • IMRX N/A
  • DBI N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • DBI Clothing/Shoe/Accessory Stores
  • Sector
  • IMRX Health Care
  • DBI Consumer Discretionary
  • Exchange
  • IMRX Nasdaq
  • DBI Nasdaq
  • Market Cap
  • IMRX 145.7M
  • DBI 136.7M
  • IPO Year
  • IMRX 2021
  • DBI 1991
  • Fundamental
  • Price
  • IMRX $4.18
  • DBI $2.82
  • Analyst Decision
  • IMRX Strong Buy
  • DBI Hold
  • Analyst Count
  • IMRX 4
  • DBI 2
  • Target Price
  • IMRX $13.25
  • DBI $3.50
  • AVG Volume (30 Days)
  • IMRX 3.2M
  • DBI 1.7M
  • Earning Date
  • IMRX 08-05-2025
  • DBI 06-10-2025
  • Dividend Yield
  • IMRX N/A
  • DBI 7.12%
  • EPS Growth
  • IMRX N/A
  • DBI N/A
  • EPS
  • IMRX N/A
  • DBI N/A
  • Revenue
  • IMRX N/A
  • DBI $2,949,575,000.00
  • Revenue This Year
  • IMRX N/A
  • DBI N/A
  • Revenue Next Year
  • IMRX N/A
  • DBI $2.45
  • P/E Ratio
  • IMRX N/A
  • DBI N/A
  • Revenue Growth
  • IMRX N/A
  • DBI N/A
  • 52 Week Low
  • IMRX $1.00
  • DBI $2.18
  • 52 Week High
  • IMRX $4.60
  • DBI $8.45
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 68.29
  • DBI 56.50
  • Support Level
  • IMRX $3.95
  • DBI $2.37
  • Resistance Level
  • IMRX $4.55
  • DBI $3.20
  • Average True Range (ATR)
  • IMRX 0.42
  • DBI 0.20
  • MACD
  • IMRX 0.04
  • DBI 0.09
  • Stochastic Oscillator
  • IMRX 75.72
  • DBI 86.70

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.

Share on Social Networks: